
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
twist2 CRISPR/Cas9 KO Plasmid (m) | sc-419989 | 20 µg | $397.00 |
Twist2 encodes a basic helix–loop–helix (bHLH) transcription factor that regulates mesenchymal lineage programs, controlling cell fate decisions, proliferation, and differentiation during embryogenesis and tissue homeostasis. In mouse, twist2 influences transcriptional networks linked to epithelial–mesenchymal transition (EMT)-like processes, extracellular matrix remodeling, and crosstalk with pathways such as TGF-β and Wnt that shape morphogenesis and stromal cell behavior. Altered TWIST2 activity has been associated with developmental abnormalities and dysregulated inflammatory and fibrotic responses, making it a useful node for studying gene regulatory circuitry in connective tissue biology. Loss-of-function models support investigation of how Twist2 coordinates transcriptional repression/activation programs in fibroblasts, myogenic precursors, and immune-associated stromal compartments.
twist2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Twist2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Twist2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Twist2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish twist2 protein expression.
This CRISPR knockout system enables efficient generation of Twist2-deficient cell models for investigation of twist2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.